Loading…
This event has ended. Create your own event on Sched.
T

tluan@glaukos.com

Thursday, March 1
 

6:59am EST

7:00am EST

Moderated Poster Session (PO001-PO049) Astor Ballroom PO001: Long-Term Iop Control With One, Two, Or Three Trabecular Micro-Bypass Stents For Open Angle Glaucoma: 54 Month Outcomes Astor BallroomOluwatosin Smith MD PO002: Long-Term Outcomes Of A Prospective Study Of Two Trabecular Micro-Bypass Stents Vs. Prostaglandin In Newly Diagnosed Open-Angle Glaucoma: 5-Year Follow-Up Astor BallroomRobert Fechtner MD PO003: Comparison Of One Vs. Two Trabecular Micro-Bypass Stents Astor BallroomSien Chen MD PO004: Outcomes Through 48 Months Following Standalone Implantation Of Migs With 2 Trabecular Bypass Stents In Eyes With Oag Not Controlled On 1 Medication Astor BallroomJason Bacharach MD PO005: Long-Term 48-Month Outcomes Of Refractory Glaucoma Patients Treated With Two Trabecular Micro-Bypass Stents, One Suprachoroidal Stent, And A Topical Prostaglandin. Astor BallroomHady Saheb MD MPH PO006: To Evaluate (1) Impact Of Implanting 2 Trabecular Bypass Microstents On Intra-Ocular Pressure And Medication Burden. (2) Intra-Operative Assessment Of Dye Uptake By The Episcleral Vasculature As A Predictor... Astor BallroomAndrew Chen MD PO007: Treatment With Standalone Implantation Of 2 Trabecular Micro-Bypass Stents Combined With Topical Prostaglandin In OAG On 2 Preoperative Medications: 4-Year Outcomes. Astor BallroomSteven Vold MD PO008: Single-Surgeon Experience With Trabecular Micro-Bypass Stent Implanted In Combination With Cataract Surgery In Eyes With Prior Medical And/Or Surgical Glaucoma Therapy: 5-Year Outcomes Astor BallroomMichael Stiles MD PO009: IOP And Medication Reduction After MIGS With Second-Generation Trabecular Bypass Stents In OAG Subjects On 1 Preoperative Medication: 30-Month Post-Op Outcomes Astor BallroomSavak Teymoorian MD MBA PO010: MIGS With 2 Second-Generation Trabecular Bypass Stents Combined With Topical Prostaglandin In Eyes With OAG On 2 Preoperative Medications: 30-Month Outcomes Astor BallroomAnand Mantravadi MD PO011: Evaluation Of Second-Generation Trabecular Micro-Bypass Stents In Patients With Mild To Severe Glaucoma : A Canadian Study Astor BallroomJulie Lapointe MD PO012: Predictors Of Clinical Outcomes In Combined Phacoemulsification-Istent Astor BallroomShaza Al-Holou MD PO013: Surgical Outcomes Following Combined Phacoemulsification With Istent Implantation And Ab Interno Trabeculectomy Using The Kahook Dual Blade In Patients With Open Angle Glaucoma Astor BallroomCrystal Le MD MPH PO014: Intermediate Term Outcome Of Istent And Istent Inject In Combination With Phacoemulsification Astor BallroomJithin Yohannan MD MPH PO015: Histologic Analysis Of Trabecular Meshwork Obtained From Kahook Dual Blade Goniotomy Astor BallroomSwarup Swaminathan MD PO016: Early Results Of The Kahook Dual Blade, A Novel Device For The Treatment Of Glaucoma Astor BallroomDavinder Grover MD MPH PO017: Outcomes Of Kahook Dual Blade Goniotomy With And Without Phacoemulsification Cataract Extraction Astor BallroomErin Sieck MD PO018: Six-Month Outcomes Of Goniotomy Performed With The Kahook Dual Blade As A Stand-Alone Glaucoma Procedure Astor BallroomSyril Dorairaj MD PO019: Safety And Efficacy Of Kahook Dual Blade With And Without Phacoemulsification Astor BallroomSze Wong MD PO020: Diurnal IOP Fluctuation After Placement Of An Ab Interno Gelatin Stent In Patients With Glaucoma Astor BallroomArsham Sheybani MD PO021: Evaluation Of Efficacy Of Xen Gel Stent - 6 Month Follow-Up Astor BallroomMarc Toeteberg-Harms MD FEBO PO022: Supraciliary Micro-Stent Is Associated With Lack Of Disease Progression And Minimum Usage Of IOP Lowering Medications In Patients With Poag 2-Years Post-Implantation Astor BallroomBrian Flowers MD PO023: Evaluation Of A 24 Hour Circadian Rhythm Model For Iop After Implant With A Supraciliary Micro-Stent Astor BallroomBrian A. Francis MD PO027: Outflow Facility Effects Of Three Schlemm's Canal MIGS Astor BallroomCarol Toris PhD PO028: Evaluation Of Micro-Invasive Glaucoma Surgery Devices: A Systematic Review And Meta-Analysis Astor BallroomCindy Hutnik MD PhD PO029: Is There A Role For Microinvasive Glaucoma Surgery In Lowering Intraocular Pressure In Presence Of Prior Incisional Glaucoma Surgeries? Astor BallroomShakeel R. Shareef MD PO030: Qualitative Input To Develop A Health-Related Quality-Of-Life Survey For Glaucoma Patients With Micro-Invasive Glaucoma Devices Astor BallroomQi Cui MD PhD PO031: Identifying And Prioritizing Outcomes That Matter To Patients Considering Minimally Invasive Glaucoma Surgical (MIGS) Devices And Other Treatments For Open-Angle Glaucoma Astor BallroomJimmy Le MA

9:05am EST

9:17am EST

9:29am EST

9:53am EST

10:40am EST

11:13am EST

11:14am EST

11:20am EST

11:27am EST

11:34am EST

11:41am EST

11:48am EST

11:55am EST

12:02pm EST

2:55pm EST

3:05pm EST

3:17pm EST

3:22pm EST

5:30pm EST

 
Friday, March 2
 

6:00am EST

6:59am EST

7:00am EST

8:06am EST

8:41am EST

9:05am EST

9:06am EST

9:20am EST

9:35am EST

9:50am EST

10:05am EST

10:20am EST

11:25am EST

11:57am EST

5:20pm EST

 
Saturday, March 3
 

6:00am EST

7:00am EST

8:06am EST

8:17am EST

8:29am EST

8:53am EST

9:05am EST

9:06am EST

9:10am EST

9:19am EST

9:28am EST

9:37am EST

9:46am EST

9:55am EST

10:04am EST

10:13am EST

10:22am EST

12:10pm EST

3:47pm EST

4:00pm EST

 
Sunday, March 4
 

7:00am EST